Randomized

A 12-week, Randomized, Parallel-Group, Proof-of-Concept Study of Tulobuterol Patch and Salmeterol Inhaler as Add-on Therapy in Adult-Onset Mild-to-Moderate Asthma.

Related Articles A 12-week, Randomized, Parallel-Group, Proof-of-Concept Study of Tulobuterol Patch and Salmeterol Inhaler as Add-on Therapy in Adult-Onset Mild-to-Moderate Asthma. Clin Exp Pharmacol Physiol. 2016 Oct 8;: Authors: Inoue H, Niimi A, Matsumoto H, Ito I, Oguma T, Otsuka…

A Multicenter Randomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Patients With Asthma

Condition:   AsthmaInterventions:   Drug: QMF149;   Drug: QMF149;   Drug: MF 400;   Drug: MF 400;   Drug: salmeterol /fluticasoneSponsor:   Novartis PharmaceuticalsNot yet recruiting – verified September 2015 View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Two Doses of the Intravenous Magnesium Sulfate Versus the Standard Single Dose ,With/ Without the Nebulized Budesonide For the Management of the Severe Asthma Exacerbation in the Emergency Room; A Randomized Controlled Trial.

Condition:   Bronchial AsthmaInterventions:   Drug: Intravenous magnesium sulfate;   Drug: Inhaled budesonide;   Drug: normal salineSponsor:   Hamad Medical CorporationRecruiting – verified May 2015 View full post on ClinicalTrials.gov: asthma | received in the last 14 days

A dose-ranging study of the bronchodilator effects of abediterol (LAS100977), a long-acting beta2-adrenergic agonist, in asthma; a Phase II, randomized study.

Related Articles A dose-ranging study of the bronchodilator effects of abediterol (LAS100977), a long-acting beta2-adrenergic agonist, in asthma; a Phase II, randomized study. BMC Pulm Med. 2014 Nov 14;14(1):176 Authors: Singh D, Pujol H, Ribera A, Seoane B, Massana E,…

The Effect of Intranasal Vasoconstrictor Medications on Hemodynamic Parameters: A Randomized Double-blind, Placebo-controlled Trial.

Conditions:   Epistaxis;   Blood PressureInterventions:   Drug: Oxymetazoline 0.05%;   Drug: Phenylephrine 0.25%;   Drug: Lidocaine 1% plus epinephrine 1:100,000;   Drug: Bacteriostatic 0.9% NaCLSponsor:   Mayo ClinicRecruiting – verified November 2014 View full post on ClinicalTrials.gov: asthma | received in the last 14 days

A Randomized Trial of Rectal Indomethacin and Papillary Spray of Epinephrine Versus Rectal Indomethacin to Prevent Post-ERCP Pancreatitis in High Risk Patients

Condition:   Post-ERCP Acute PancreatitisInterventions:   Drug: Rectal Indomethacin;   Drug: EpinephrineSponsors:   Johns Hopkins University;   American Society for Gastrointestinal Endoscopy;   Asian Institute of Gastroenterology, India;   Postgraduate Institute of Medical Education and Research;   Apollo Gleneagles Hospitals, IndiaNot yet recruiting – verified April 2014 View full post on ClinicalTrials.gov: asthma | received in the last…